Cancer-prone cell states of the fallopian tubal epithelium
输卵管上皮细胞的易癌状态
基本信息
- 批准号:10397606
- 负责人:
- 金额:$ 42.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:BiologicalBreast CarcinomaCarcinomaCell LineageCellsCharacteristicsChargeClinicalConsensusDataDiagnosisDiseaseDissociationDistalEpithelialEpithelial CellsEpithelial ovarian cancerFrequenciesGenetic TranscriptionGenomicsGrowth FactorHeterogeneityHumanImplantInflammatoryMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of ovaryMammalian OviductsMechanicsMesenchymalModalityMolecular AbnormalityMolecular ProfilingMorphologyMusMutationNatural regenerationNeoplasm MetastasisOrganoidsOvarianOvarian CarcinomaPatientsPopulationPredispositionPrognostic MarkerProstate carcinomaReportingRoleSerousSignal TransductionStratificationStromal CellsStromal ChangeSurfaceSurvival RateSymptomsSystemTestingTubeWomanbasebiomarker developmentcancer cellcancer typecell typecellular developmentdiagnostic biomarkergenetic signatureimmunoreactivityinsightmutantnovel therapeuticsresponsestemstem cellstranscriptometranscriptomicstreatment responsetumor
项目摘要
Project Summary
Ovarian/extra-uterine high-grade serous carcinoma (HGSC) is the most common and aggressive type of ovarian
cancer. It often has no symptoms at early stages and over 80% of patients are diagnosed at advanced, usually
incurable, cancer stages, when the tumors have already metastasized. Extensive integrated genomic analysis
allowed identification of several clinically distinct subtypes of HGSC. A significant fraction of HGSC arises from
the tubal epithelium (TE) located in the distal region of Fallopian tube (aka uterine tube or oviduct). Recent single
cell transcriptome analysis of distal TE inferred that HGSC heterogeneity could be connected to diverse cell
states present in TE cell lineages. Unfortunately, precise cell lineage-based hierarchy of identified TE cell types
has not been yet established. Furthermore, cancer-prone cellular states of TE are insufficiently defined and
factors influencing such states remain unclear. Thus, it remains unknown if uneven clinical course of HGSC and
development of cellular therapeutic responses may reflect different modes of initiation and progression of this
malignancy. Our preliminary studies show that, in addition to known secretory (OVGP1+) and ciliated (FOXJ1+,
CD24+) epithelial cells, there are several epithelial cell populations characterized by preferential expression of
stem/progenitor cell markers, such as SLC1A3, CD49f (ITGA6), and KLF6. A Monocle cell-lineage trajectory
prediction analysis of our single-cell transcriptomic data identified a population of SLC1A3+ stem/progenitor cells
that give rise to both secretory and ciliated cells by progressing through transient intermediates, including a
KRT5+ cell population. This prediction has been confirmed by lineage tracing of SLC1A3+ cells and ex vivo
studies. Cells in a transient state (CD24med CD49f+) form spheres in consecutive rounds of sphere dissociation-
regeneration and express KRT5. Under normal homeostatic conditions, KRT5+ cells are largely dormant and
minimally contribute to secretory and ciliated cell lineages. However, KRT5+ cells become actively involved in
re-epithelialization after mechanical damage. Our preliminary results suggest that stromal charges begin to co-
evolve with mutant epithelial cells before the earliest morphologically detectable alterations. Based on previous
studies and our preliminary results we hypothesize that cancer-prone TE cell states are determined by levels of
epithelial damage and stromal milieu changes. To test this hypothesis we propose (1) to establish the role of
specific cell states during homeostatic and posttraumatic regeneration, (2) to determine the impact of epithelial
damage on cancer susceptibility of epithelial states and (3) to identify and characterize epithelial and stromal cell
lineage dynamics during early stages of TE malignant transformation.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Y Nikitin其他文献
Alexander Y Nikitin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Y Nikitin', 18)}}的其他基金
Cancer-prone cell states of the fallopian tubal epithelium
输卵管上皮细胞的易癌状态
- 批准号:
10184438 - 财政年份:2021
- 资助金额:
$ 42.09万 - 项目类别:
Cancer-prone cell states of the fallopian tubal epithelium
输卵管上皮细胞的易癌状态
- 批准号:
10625966 - 财政年份:2021
- 资助金额:
$ 42.09万 - 项目类别:
Neuroendocrine mechanisms of prostate cancer progression
前列腺癌进展的神经内分泌机制
- 批准号:
9291444 - 财政年份:2015
- 资助金额:
$ 42.09万 - 项目类别:
Neuroendocrine mechanisms of prostate cancer progression
前列腺癌进展的神经内分泌机制
- 批准号:
10245737 - 财政年份:2015
- 资助金额:
$ 42.09万 - 项目类别:
Modeling ovarian carcinoma by defined genetic alterations
通过定义的遗传改变来模拟卵巢癌
- 批准号:
7666760 - 财政年份:2005
- 资助金额:
$ 42.09万 - 项目类别:
Modeling ovarian carcinoma by defined genetic alterations
通过定义的遗传改变来模拟卵巢癌
- 批准号:
6983701 - 财政年份:2005
- 资助金额:
$ 42.09万 - 项目类别:
Modeling ovarian carcinoma by defined genetic alterations
通过定义的遗传改变来模拟卵巢癌
- 批准号:
7118757 - 财政年份:2005
- 资助金额:
$ 42.09万 - 项目类别:
相似海外基金
Development of Novel Immune Checkpoint Blockade Therapies in Mouse Models of Invasive Lobular Breast Carcinoma
在侵袭性小叶乳腺癌小鼠模型中开发新型免疫检查点阻断疗法
- 批准号:
486202 - 财政年份:2022
- 资助金额:
$ 42.09万 - 项目类别:
Studentship Programs
Modulation of circadian clock and its therapeutic implications in invasive breast carcinoma
生物钟的调节及其对浸润性乳腺癌的治疗意义
- 批准号:
20K17585 - 财政年份:2020
- 资助金额:
$ 42.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring novel therapeutic target molecules for metaplastic breast carcinoma using comprehensive genome-wide gene expression analyses
利用全面的全基因组基因表达分析探索化生性乳腺癌的新型治疗靶分子
- 批准号:
19K16715 - 财政年份:2019
- 资助金额:
$ 42.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Functional analysis of clock genes in invasive breast carcinoma
浸润性乳腺癌时钟基因的功能分析
- 批准号:
17K17575 - 财政年份:2017
- 资助金额:
$ 42.09万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Collagen structural changes as an early biomarker for breast carcinoma
胶原蛋白结构变化作为乳腺癌的早期生物标志物
- 批准号:
9133341 - 财政年份:2015
- 资助金额:
$ 42.09万 - 项目类别:
Collagen structural changes as an early biomarker for breast carcinoma
胶原蛋白结构变化作为乳腺癌的早期生物标志物
- 批准号:
9344562 - 财政年份:2015
- 资助金额:
$ 42.09万 - 项目类别:
Collagen structural changes as an early biomarker for breast carcinoma
胶原蛋白结构变化作为乳腺癌的早期生物标志物
- 批准号:
9764150 - 财政年份:2015
- 资助金额:
$ 42.09万 - 项目类别:
Detection of estrogen receptor dimerization patter in breast carcinoma tissues.
乳腺癌组织中雌激素受体二聚化模式的检测。
- 批准号:
25670174 - 财政年份:2013
- 资助金额:
$ 42.09万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Histopathological approach for early invasive breast carcinoma
早期浸润性乳腺癌的组织病理学方法
- 批准号:
25460467 - 财政年份:2013
- 资助金额:
$ 42.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Reproducibility of Basal-like Breast Carcinoma Immunohistochemical Panels: A Survey of Diagnostic Pathology Laboratories in Canada, the USA, Belgium, Brazil and the UK
基底样乳腺癌免疫组织化学组的再现性:加拿大、美国、比利时、巴西和英国诊断病理学实验室的调查
- 批准号:
294341 - 财政年份:2013
- 资助金额:
$ 42.09万 - 项目类别: